To: Board of Supervisors
From: Anna Roth, Health Services Director
Report Title: Purchase Order with Thermo Fisher Scientific (Asheville) LLC
☒Recommendation of the County Administrator ☐ Recommendation of Board Committee
RECOMMENDATIONS:
APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, a purchase order with Thermo Fisher Scientific (Asheville) LLC in an amount not to exceed $1,099, and Instrument Service Agreement Quote for the purchase of preventative maintenance and services for a refrigerator at the Contra Costa Regional Medical Center Inpatient Pharmacy for the period from October 3, 2024 through October 2, 2025.
FISCAL IMPACT:
Approval of this action will result in an expenditure of $1,099 and will be funded by the Hospital Enterprise Fund I revenues.
BACKGROUND:
In 2014 the Inpatient pharmacy received a Thermo Fisher refrigerator for the storage of IV medications for use at CCRMC from Baxter Healthcare. Once order qualifications were met in 2017, Baxter Healthcare transferred ownership of the refrigerator to Contra Costa County. Since that time the Inpatient pharmacy has maintained a warranty agreement with Thermo Fisher in case of failure or service maintenance using a purchase order.
On October 24, 2023, the Board of Supervisors approved agenda item C.37 to execute a purchase order with Thermo Fisher Scientific (Asheville) LLC in an the amount of $1,095.00, and related agreement for the period of October 3,2023 through October 2, 2024.
Execution of the Instrument Service Agreement Quote includes agreeing to the contractor's Terms and Conditions of Service. Those terms and conditions contain limited liability provisions, which limit the contractor's liability such that it's total liability will not exceed the charge paid by the County for the services provided.
CONSEQUENCE OF NEGATIVE ACTION:
If this purchase order is not approved, the CCRMC Inpatient Pharmacy will not be able to purchase the warranty to cover the refrigerator in case of failure.